Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. A-623 (Blisibimod) is Anthera’s leading drug candidate which is being developed for treatment of both systemic lupus erythematosus and IgA nephropathy.
Wikipage redirect
primaryTopic
Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. A-623 (Blisibimod) is Anthera’s leading drug candidate which is being developed for treatment of both systemic lupus erythematosus and IgA nephropathy.
has abstract
Anthera Pharmaceuticals, Inc. ...... hematosus and IgA nephropathy.
@en
founding year
industry
key person
type
Link from a Wikipage to an external page
Wikipage page ID
32,640,454
Wikipage revision ID
673,498,087
subject
comment
Anthera Pharmaceuticals, Inc. ...... hematosus and IgA nephropathy.
@en
label
Anthera Pharmaceuticals
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Anthera Pharmaceuticals, Inc.
@en